Meta Biomed Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
63,518
61,365
68,592
65,784
65,341
Cost of Goods Sold (COGS) incl. D&A
44,566
45,348
43,883
42,988
43,064
Gross Income
18,953
16,017
24,709
22,796
22,277
SG&A Expense
14,452
16,172
18,162
18,775
20,531
EBIT
4,501
155
6,547
-
1,603
Unusual Expense
555
3,909
2,147
1,494
3,806
Non Operating Income/Expense
2,298
592
241
116
401
Interest Expense
3,311
3,156
2,176
1,494
1,860
Pretax Income
3,050
6,488
2,085
1,919
4,112
Income Tax
90
1,957
1,394
1,170
31
Equity in Affiliates
1,154
243
279
-
-
Consolidated Net Income
1,985
4,774
970
749
4,081
Net Income
1,968
4,952
806
639
4,211
Net Income After Extraordinaries
1,766
4,952
806
639
4,211
Net Income Available to Common
2,171
4,952
806
639
4,211
EPS (Basic)
128.00
286.00
39.00
30.00
196.00
Basic Shares Outstanding
17
17
21
22
22
EPS (Diluted)
103.92
222.55
33.84
28.40
195.77
Diluted Shares Outstanding
21
22
24
22
22
EBITDA
7,729
3,255
10,184
7,738
4,927
Other Operating Expense
-
-
-
-
143
Non-Operating Interest Income
117
140
102
74
80
Minority Interest Expense
17
178
164
110
129
Equity in Affiliates (Pretax)
-
-
-
696
272
About Meta Biomed Co.
View Profile
